GCH1 in early-onset Parkinson's disease

Movement Disorders

Volumn 24, Issue 14, 2009, Pages 2070-2075

  Cobb, Stephanie A ^a   Wider, Christian ^a,b   Ross, Owen A ^a   Mata, Ignacio F ^c   Adler, Charles H ^d   Rajput, Alex ^e   Rajput, Ali H ^e   Wu, Ruey Meei ^f   Hauser, Robert ^g   Josephs, Keith A ^h   Carr, Jonathan ⁱ   Gwinn, Katrina ^j   Heckman, Michael G ^a   Aasly, Jan O ^k   Lynch, Timothy ^l   Uitti, Ryan J ^b   Wszolek, Zbigniew K ^b   Kapatos, Gregory ^m   Farrer, Matthew J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e ROYAL UNIVERSITY HOSPITAL   (Canada)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

^h MAYO CLINIC   (United States)

ⁱ STELLENBOSCH UNIVERSITY   (South Africa)

^j BAYLOR COLLEGE OF MEDICINE   (United States)

^k NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^l MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^m WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Dopa responsive dystonia; DRD; Early onset Parkinson's disease; GCH1; Parkinson's disease; PRKN

Indexed keywords

CYTOSINE; DJ 1 PROTEIN; GENE PRODUCT; GUANINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; PARKIN; PROTEIN PINK1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DYSTONIA; FEMALE; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; DNA; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENETIC VARIATION; GTP CYCLOHYDROLASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NORTH AMERICA; ONCOGENE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN KINASES; UBIQUITIN-PROTEIN LIGASES;

EID: 70450191118     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22729     Document Type: Article

References (25)

1. Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003;54 (Suppl. 6):S32-S45. (Pubitemid 36903852)
2. Furukawa Y. Update on dopa-responsive dystonia: locus heterogeneity and biochemical features. Adv Neurol 2004;94:127-138.
3. Wider C, Melquist S, Hauf M, et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology 2008;70 (16, Pt. 2):1377-1383.
4. Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology 1990;40:66-69. (Pubitemid 20032895)
5. Furukawa Y, Lang AE, Trugman JM, et al. Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology 1998;50:1015-1020. (Pubitemid 28212831)
6. Momma K, Funayama M, Li Y, et al. A new mutation in the GCH1 gene presents as early-onset Parkinsonism. Parkinsonism Relat Disord 2009;15:160-161.
7. Romstad A, Dupont E, Krag-Olsen B, Ostergaard K, Guldberg P, Guttler F. Dopa-responsive dystonia and Tourette syndrome in a large Danish family. Arch Neurol 2003;60:618-622. (Pubitemid 36427979)
8. Tassin J, Durr A, Bonnet AM, et al. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain 2000;123 (Pt. 6):1112-1121.
9. Ichinose H, Ohye T, Takahashi E, et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994;8:236-242. (Pubitemid 24338734)
10. Thony B, Blau N. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Hum Mutat 2006;27:870-878. (Pubitemid 44336936)
11. Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 2003;126 (Pt. 6):1271-1278. (Pubitemid 36644374)
12. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126 (Pt. 6):1279-1292. (Pubitemid 36644375)
13. Mata IF, Lockhart PJ, Farrer MJ. Parkin genetics: one model for Parkinson's disease. Hum Mol Genet 2004;13:R127-R133. (Pubitemid 38443806)
14. Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 2006;7:306-318.
15. Hjermind LE, Johannsen LG, Blau N, et al. Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency? Mov Disord 2006;21:679-682.
16. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
17. Hirayama K, Shimoji M, Swick L, Meyer A, Kapatos G. Characterization of GTP cyclohydrolase I gene expression in the human neuroblastoma SKN-BE(2)M17: enhanced transcription in response to cAMP is conferred by the proximal promoter. J Neurochem 2001;79:576-587.
18. Toft M, Myhre R, Pielsticker L, White LR, Aasly JO, Farrer MJ. PINK1 mutation heterozygosity and the risk of Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:82-84. (Pubitemid 46048269)
19. Farrer M, Chan P, Chen R, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001;50:293-300. (Pubitemid 32848731)
20. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-434.
21. Kapatos G, Stegenga SL, Hirayama K. Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat GTP cyclohydrolase I gene. J Biol Chem 2000;275:5947-5957. (Pubitemid 30115244)
22. Al Sarraj J, Vinson C, Han J, Thiel G. Regulation of GTP cyclohydrolase I gene transcription by basic region leucine zipper transcription factors. J Cell Biochem 2005;96:1003-1020. (Pubitemid 41688725)
23. Chandran NS, Vunnava P, Wu Y, Kapatos G. Specificity proteins Sp1 and Sp3 interact with the rat GTP cyclohydrolase I proximal promoter to regulate transcription. J Neurochem 2008;104:1233-1248. (Pubitemid 351293335)
24. Hertz JM, Ostergaard K, Juncker I, et al. Low frequency of Parkin, tyrosine hydroxylase, and GTP cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's disease. Eur J Neurol 2006;13:385-390.
25. Zhang L, Rao F, Zhang K, et al. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk. J Clin Invest 2007;117:2658-2671. (Pubitemid 47494366)